Search

everythinglearnresearchcommunity

for

Search:↓

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

The vitamin D receptor helps control hair growth and may protect against certain skin tumors.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Alopecia areata involves unique activation of certain immune cells.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

A vitamin D receptor mutation causes rickets and affects immune responses.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Vitamin D receptor is essential for proper skin healing after injury.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Vitamin D receptor helps control hair growth and could be used to treat certain skin tumors.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

A new mouse model effectively mimics vitiligo for research and drug testing.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.